71 related articles for article (PubMed ID: 17989608)
1. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
[TBL] [Abstract][Full Text] [Related]
2. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.
Song L; Ma A; Dun H; Hu Y; Zeng L; Bai J; Zhang G; Kinugasa F; Sudo Y; Miyao Y; Okimura K; Miura T; Daloze P; Chen H
Transplantation; 2014 Aug; 98(3):267-76. PubMed ID: 24992357
[TBL] [Abstract][Full Text] [Related]
3. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival.
Lassiter G; Otsuka R; Hirose T; Rosales I; Karadagi A; Tomosugi T; Dehnadi A; Lee H; Colvin RB; Baardsnes J; Moraitis A; Smith EE; Ali Z; Berhe P; Mulder A; Meibohm B; Daugherty B; Fogarty S; Pierson RN; Lederman S; Kawai T
Am J Transplant; 2023 Aug; 23(8):1171-1181. PubMed ID: 37019335
[TBL] [Abstract][Full Text] [Related]
4. Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects.
Okimura K; Maeta K; Kobayashi N; Goto M; Kano N; Ishihara T; Ishikawa T; Tsumura H; Ueno A; Miyao Y; Sakuma S; Kinugasa F; Takahashi N; Miura T
Am J Transplant; 2014 Jun; 14(6):1290-9. PubMed ID: 24731050
[TBL] [Abstract][Full Text] [Related]
5. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival.
Miura S; Habibabady ZA; Pollok F; Ma M; Rosales IA; Kinoshita K; Pratts S; McGrath G; Chaban R; Fogarty S; Meibohm B; Daugherty B; Lederman S; Pierson RN
Am J Transplant; 2023 Aug; 23(8):1182-1193. PubMed ID: 37030662
[TBL] [Abstract][Full Text] [Related]
6. In vitro testing of an anti-CD40 monoclonal antibody, clone 2C10, in primates and pigs.
Lee W; Satyananda V; Iwase H; Tanaka T; Miyagawa Y; Long C; Ayares D; Cooper DK; Hara H
Transpl Immunol; 2015 Nov; 33(3):185-91. PubMed ID: 26458513
[TBL] [Abstract][Full Text] [Related]
7. The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates.
Anwar IJ; Berman DM; DeLaura I; Gao Q; Willman MA; Miller A; Gill A; Gill C; Perrin S; Ricordi C; Ruiz P; Song M; Ladowski JM; Kirk AD; Kenyon NS
Sci Transl Med; 2023 Aug; 15(711):eadf6376. PubMed ID: 37647390
[TBL] [Abstract][Full Text] [Related]
8. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy.
Aoyagi T; Yamashita K; Suzuki T; Uno M; Goto R; Taniguchi M; Shimamura T; Takahashi N; Miura T; Okimura K; Itoh T; Shimizu A; Furukawa H; Todo S
Am J Transplant; 2009 Aug; 9(8):1732-41. PubMed ID: 19519810
[TBL] [Abstract][Full Text] [Related]
9. The Entangled World of Memory T Cells and Implications in Transplantation.
Alexander KL; Ford ML
Transplantation; 2024 Jan; 108(1):137-147. PubMed ID: 37271872
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions.
Anwar IJ; DeLaura IF; Gao Q; Ladowski J; Jackson AM; Kwun J; Knechtle SJ
Front Immunol; 2022; 13():903068. PubMed ID: 35757745
[TBL] [Abstract][Full Text] [Related]
11. The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis.
Perrin S; Magill M
Front Immunol; 2022; 13():861471. PubMed ID: 35464470
[TBL] [Abstract][Full Text] [Related]
12. Endogenous memory T cells with donor-reactivity: early post-transplant mediators of acute graft injury in unsensitized recipients.
Koritzinsky EH; Tsuda H; Fairchild RL
Transpl Int; 2021 Aug; 34(8):1360-1373. PubMed ID: 33963616
[TBL] [Abstract][Full Text] [Related]
13. Targeting co-stimulatory molecules in autoimmune disease.
Edner NM; Carlesso G; Rush JS; Walker LSK
Nat Rev Drug Discov; 2020 Dec; 19(12):860-883. PubMed ID: 32939077
[TBL] [Abstract][Full Text] [Related]
14. Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity.
Yu X; Chan HTC; Fisher H; Penfold CA; Kim J; Inzhelevskaya T; Mockridge CI; French RR; Duriez PJ; Douglas LR; English V; Verbeek JS; White AL; Tews I; Glennie MJ; Cragg MS
Cancer Cell; 2020 Jun; 37(6):850-866.e7. PubMed ID: 32442402
[TBL] [Abstract][Full Text] [Related]
15. High Dimensional Renal Profiling: Towards a Better Understanding or Renal Transplant Immune Suppression.
Castro-Rojas CM; Alloway RR; Woodle ES; Hildeman DA
Curr Transplant Rep; 2019 Mar; 6(1):60-68. PubMed ID: 31595214
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD40 antibody 2C10 binds to a conformational epitope at the CD40-CD154 interface that is conserved among primate species.
Michaels AJ; Stoppato M; Flores WJ; Reimann KA; Engelman KD
Am J Transplant; 2020 Jan; 20(1):298-305. PubMed ID: 31430418
[TBL] [Abstract][Full Text] [Related]
17. Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism.
Oura T; Hotta K; Rosales I; Dehnadi A; Kawai K; Lee H; Benedict Cosimi A; Kawai T
Transplantation; 2019 Jan; 103(1):168-176. PubMed ID: 30113996
[TBL] [Abstract][Full Text] [Related]
18. Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.
OʼNeill NA; Zhang T; Braileanu G; Sun W; Cheng X; Hershfeld A; Laird CT; Kronfli A; Hock LA; Dahi S; Kubicki N; Sievert E; Hassanein W; Cimeno A; Pierson RN; Azimzadeh AM
Transplantation; 2017 Sep; 101(9):2038-2047. PubMed ID: 28557955
[TBL] [Abstract][Full Text] [Related]
19. Role of Memory T Cells in Allograft Rejection and Tolerance.
Benichou G; Gonzalez B; Marino J; Ayasoufi K; Valujskikh A
Front Immunol; 2017; 8():170. PubMed ID: 28293238
[TBL] [Abstract][Full Text] [Related]
20. Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.
Kean LS; Turka LA; Blazar BR
Immunol Rev; 2017 Mar; 276(1):192-212. PubMed ID: 28258702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
